Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Infographic – Conventional Clinical Trial Process

Clinical trial process graphic

Click on image for full-size view (CB Insights)

5 June 2021. Science & Enterprise reports on many clinical trials, but also on efforts to improve the ways these studies are conducted. The technology market research company CB Insights recently issued a report (registration required) on companies working to reduce the long time and high cost of most clinical trials that includes a chart showing why the process is in such dire need of disruption.

The graphic — click on the image above for a full-size view — shows the many steps needed for prospects to find, enroll, and participate in a clinical trial, as well as the follow-up process by the study team. Moreover, many of those steps are labor-intensive and impose substantial time or cost burdens on participants and caregivers, particularly those living some distance from a clinical trial site. The CB Insights report points out a number of companies designing more efficient ways of collecting and analyzing clinical trial data that take advantage of mobile technology to ease travel burdens on participants, electronic health records to reduce the volume of data required from participants, and artificial intelligence to speed the analysis.

Adaptive trials are another cost- and time-saving innovation that enable clinical studies testing multiple treatments to share a common protocol and administrators, as well as make changes in design while the study is underway. NIH’s Activ trials of Covid-19 therapies are a current example of adaptive trials. And better use of real-world evidence, from electronic health and insurance claim records, are being tested as an alternative to post-marketing studies that report on long-term treatment effects.

More from Science & Enterprise:

*     *     *

Comments are closed.